Oncosil Medical Ltd has released a press release.
CEO Remuneration Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from OncoSil Medical
- Capital Raising Presentation
- Prospectus
- $8.0 million Capital Raise for Ongoing Commercial Expansion
- Quarterly Activities/Appendix 4C Cash Flow Report
- Trading Halt
Later from OncoSil Medical
- Appendix 4D and Half Year Accounts
- Security Class Suspension from Quotation
- Security Class Reinstatement to Quotation - OSLOE
- OncoSil Medical Receives TGA Approval in Australia
- OncoSil progresses HDE with US FDA
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical